In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of ARS Pharmaceuticals Inc (NASDAQ: SPRY) closed at $15.23 in the last session, up 1.87% from day before closing price of $14.95. In other words, the price has increased by $1.87 from its previous closing price. On the day, 1.02 million shares were traded. SPRY stock price reached its highest trading level at $15.27 during the session, while it also had its lowest trading level at $14.227.
Ratios:
We take a closer look at SPRY’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 32.78 and its Current Ratio is at 32.78. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On August 13, 2024, Raymond James Upgraded its rating to Strong Buy which previously was Outperform and also upped its target price recommendation from $18 to $22.
Leerink Partners reiterated its Outperform rating for the stock on August 12, 2024, while the target price for the stock was revised from $19 to $20.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Oct 15 ’24 when Tanimoto Sarina bought 300,000 shares for $14.00 per share.
Tanimoto Sarina sold 100,000 shares of SPRY for $1,382,775 on Oct 08 ’24. The CHIEF MEDICAL OFFICER now owns 1,346,494 shares after completing the transaction at $13.83 per share. On Oct 08 ’24, another insider, Lowenthal Richard E, who serves as the PRESIDENT AND CEO of the company, sold 100,000 shares for $13.83 each. As a result, the insider received 1,382,775 and left with 1,346,494 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SPRY now has a Market Capitalization of 1476420480 and an Enterprise Value of 1257836672. For the stock, the TTM Price-to-Sale (P/S) ratio is 2952.79 while its Price-to-Book (P/B) ratio in mrq is 6.86. Its current Enterprise Value per Revenue stands at 2515.673 whereas that against EBITDA is -22.194.
Stock Price History:
Over the past 52 weeks, SPRY has reached a high of $16.50, while it has fallen to a 52-week low of $3.35. The 50-Day Moving Average of the stock is 15.56%, while the 200-Day Moving Average is calculated to be 57.21%.
Shares Statistics:
According to the various share statistics, SPRY traded on average about 1.09M shares per day over the past 3-months and 751100 shares per day over the past 10 days. A total of 96.41M shares are outstanding, with a floating share count of 49.01M. Insiders hold about 49.45% of the company’s shares, while institutions hold 38.58% stake in the company. Shares short for SPRY as of 1727654400 were 11097485 with a Short Ratio of 10.19, compared to 1724976000 on 10960219. Therefore, it implies a Short% of Shares Outstanding of 11097485 and a Short% of Float of 21.57.
